Latest in Cardiology from ACC.org

• ACC Community Health Fairs Offer Framework For Closing Gaps in Care
  A Viewpoint published in JACC: Advances makes the case that addressing persistent inequities in cardiovascular health will require scalable, community-centered approaches that bring care, education, and preventive services directly into the communities where people live.
• Leadership Gap in Structural Heart Disease Trials Persists
  Women remain underrepresented in authorship and leadership roles of clinical trials of structural heart disease (SHD), and targeted efforts and policies to diversify trial leadership may help address the downstream inequities in the generation of cardiovascular evidence, according to a systematic review and meta-analysis published Aug. 12 in JACC: Advances.
• COMBINE-AF: Extracranial Bleeding Common With OAC in AFib Treatment
  Clinically relevant extracranial bleeding affected approximately one in four patients receiving oral anticoagulation (OAC) for atrial fibrillation (AFib) over two years, potentially providing a more comprehensive measure of bleeding burden than major bleeding alone, according to a recent COMBINE-AF analysis published in Circulation.
• Long-Term ASCVD Risk Drives Expanded Statin Eligibility By 2026 Dyslipidemia Guideline
  Nearly 25 million more adults in the U.S. are eligible for statin therapy, based on recommendations in the 2026 ACC/AHA/Multisociety Dyslipidemia Guideline, compared with the previous guideline, according to original research published Aug. 12 in JACC.
• CMS Proposes Updates to Ambulatory Specialty Model For HF
  The Centers for Medicare and Medicaid Services (CMS) has proposed several changes and clarifications to the Ambulatory Specialty Model (ASM) for heart failure (HF) in the 2027 Medicare Physician Fee Schedule proposed rule.